World's Best Scientists 2026 revealed!
Alexandra Schäfer

Alexandra Schäfer

D-Index & Metrics

Microbiology

D-Index
54
Citations
20168
World Ranking
3901
National Ranking
1516

Overview

Alexandra Schäfer is a researcher affiliated with Duke University in the United States. Their primary field of study is Medicine, with a specific focus on Infectious Diseases. They have contributed to the understanding of viral infections through research spanning virology, epidemiology, neurology, and molecular biology.

Schäfer's research topics cover several key areas including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Long-Term Effects of COVID-19
  • Viral gastroenteritis research and epidemiology
  • Viral Infections and Vectors
  • Influenza Virus Research Studies

Frequent co-authors collaborating with Schäfer include:

  • Ralph S. Baric
  • Sarah R. Leist
  • Boyd L. Yount
  • Nicholas Catanzaro
  • Melissa D. Mattocks

Schäfer has published research in a variety of venues, with multiple papers appearing in UNC Libraries and Science Translational Medicine. Other publication venues include Nature Communications, Nature, and mSphere. The diversity of venues reflects the interdisciplinary nature of Schäfer's work in infectious diseases and virology.

Among their recent published papers are:

  • "Animal models of Long Covid: A hit-and-run disease," 2024, Science Translational Medicine
  • "A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein," 2025, Nature
  • "ACE2 from Pipistrellus abramus bats is a receptor for HKU5 coronaviruses," 2025, Nature Communications
  • "Dysregulation of lung epithelial cell homeostasis and immunity contributes to Middle East respiratory syndrome coronavirus disease severity," 2025, mSphere
  • "Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice," 2025, Science Translational Medicine

Best Publications

  • Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.

    Timothy P. Sheahan;Amy C. Sims;Sarah R. Leist;Alexandra Schäfer

  • SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

    Yixuan J. Hou;Kenichi Okuda;Caitlin E. Edwards;David R. Martinez

  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.

    Kizzmekia S. Corbett;Darin K. Edwards;Sarah R. Leist;Olubukola M. Abiona

  • Potently neutralizing and protective human antibodies against SARS-CoV-2.

    Seth J. Zost;Pavlo Gilchuk;James Brett Case;Elad Binshtein

  • An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

    Timothy P. Sheahan;Amy C. Sims;Shuntai Zhou;Rachel L. Graham

  • SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    Yixuan J. Hou;Shiho Chiba;Peter Halfmann;Camille Ehre

  • Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed.

    Xuezhong Cai;Alexandra Schäfer;Shihua Lu;John P Bilello

  • A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.

    Kenneth H. Dinnon;Sarah R. Leist;Alexandra Schäfer;Caitlin E. Edwards

  • A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.

    Sarah R. Leist;Kenneth H. Dinnon;Alexandra Schäfer;Longping V. Tse

  • A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.

    Ahmed O. Hassan;Natasha M. Kafai;Igor P. Dmitriev;Julie M. Fox

  • Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.

    Alexandra C. Walls;Brooke Fiala;Alexandra Schäfer;Samuel Wrenn

  • Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.

    Andrea J. Pruijssers;Andrea J. Pruijssers;Amelia S. George;Amelia S. George;Alexandra Schäfer;Sarah R. Leist

  • Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

    Allison L. Totura;Alan Whitmore;Sudhakar Agnihothram;Alexandra Schäfer

  • SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.

    Angela Wahl;Lisa E. Gralinski;Claire E. Johnson;Wenbo Yao

  • Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.

    Alexandra Schäfer;Frauke Muecksch;Julio C.C. Lorenzi;Sarah R. Leist

  • Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

    Brian P. Doehle;Alexandra Schäfer;Bryan R. Cullen

  • In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.

    Dapeng Li;Robert J. Edwards;Kartik Manne;David R. Martinez

  • Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.

    Alexandra Schäfer;Hal P. Bogerd;Bryan R. Cullen

  • Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses

    Vineet D. Menachery;Amie J. Eisfeld;Alexandra Schäfer;Laurence Josset

  • Foamy Virus Bet Proteins Function as Novel Inhibitors of the APOBEC3 Family of Innate Antiretroviral Defense Factors

    Rebecca A. Russell;Heather L. Wiegand;Michael D. Moore;Alexandra Schäfer

Frequent Co-Authors

Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Lisa E. Gralinski
Lisa E. Gralinski University of North Carolina at Chapel Hill
David R. Martinez
David R. Martinez Yale University
Vineet D. Menachery
Vineet D. Menachery The University of Texas Medical Branch at Galveston
Timothy P. Sheahan
Timothy P. Sheahan University of North Carolina at Chapel Hill
Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Mark R. Denison
Mark R. Denison Vanderbilt University Medical Center
Shannon K. McWeeney
Shannon K. McWeeney Oregon Health & Science University
James D. Chappell
James D. Chappell Vanderbilt University Medical Center
Barney S. Graham
Barney S. Graham Morehouse School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related online degrees can open up diverse career pathways in healthcare and research. One popular option is pursuing a cahiim accredited health information management degree online. This degree equips students with essential skills in managing healthcare data, a crucial element in medical research and clinical settings.

Another fast-growing field is medical billing and coding, which supports efficient healthcare operations. Prospective students can find the best fastest online medical billing and coding certificate programs that provide swift entry into this vital career, often with flexible online learning options.

Those looking to deepen their medical knowledge might consider exploring online medical degrees, which offer various specialties and convenient formats ideal for working professionals or remote learners.

Additionally, public health is a complementary discipline to Microbiology with numerous opportunities for impact. Students may find easy admission online mph programs that lower entry barriers, allowing more individuals to advance their careers in population health and epidemiology.

Connecting Microbiology studies with these related online degrees broadens career options and enhances employability across the healthcare sector.

Best Scientists Citing Alexandra Schäfer

Trending Scientists

Recently Published Articles